» Articles » PMID: 20128684

Analyzing the Protease Web in Skin: Meprin Metalloproteases Are Activated Specifically by KLK4, 5 and 8 Vice Versa Leading to Processing of ProKLK7 Thereby Triggering Its Activation

Overview
Journal Biol Chem
Specialty Biochemistry
Date 2010 Feb 5
PMID 20128684
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The metalloproteases meprin alpha and beta are expressed in several tissues, leukocytes, and cancer cells. In skin, meprins are located in separate layers of human epidermis indicating distinct physiological functions, supported by effects on cultured keratinocytes. Meprin beta induces a dramatic change in cell morphology and a significant reduction in cell number, whereas in vitro evidence suggests a role for meprin alpha in basal keratinocyte proliferation. Meprins are secreted as zymogens that are activated by tryptic proteolytical processing. Here, we identify human kallikrein-related peptidases (KLKs) 4, 5, and 8 to be specific activators of meprins. KLK5 is capable of activating both metalloproteases. Interestingly, KLK4 and 8 cleave off the propeptide of meprin beta only, whereas in contrast plasmin exclusively transforms meprin alpha to its mature form. Moreover, we show that proKLK7 is processed by meprins. N-terminal sequencing revealed cleavage by meprin beta two amino acids N-terminal to mature KLK7. Interestingly, this triggering led to an accelerated activation of the serine protease in the presence of trypsin, but not of other tryptic KLKs, such as KLK2, 4, 5, 8, or 11. In summary, we demonstrate a specific interaction between meprin metalloproteases and kallikrein-related peptidases, revealing possible interactions within the proteolytic web.

Citing Articles

Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways.

Petrova E, Lopez-Gay J, Fahrner M, Leturcq F, de Villartay J, Barbieux C Commun Biol. 2024; 7(1):152.

PMID: 38316920 PMC: 10844249. DOI: 10.1038/s42003-024-05780-y.


Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Srinivasan S, Kryza T, Batra J, Clements J Nat Rev Cancer. 2022; 22(4):223-238.

PMID: 35102281 DOI: 10.1038/s41568-021-00436-z.


Characterization of the Cancer-Associated Meprin Βeta Variants G45R and G89R.

Gellrich A, Scharfenberg F, Peters F, Sammel M, Helm O, Armbrust F Front Mol Biosci. 2021; 8:702341.

PMID: 34692768 PMC: 8526939. DOI: 10.3389/fmolb.2021.702341.


A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.

Lovell S, Zhang L, Kryza T, Neodo A, Bock N, De Vita E J Am Chem Soc. 2021; 143(23):8911-8924.

PMID: 34085829 PMC: 9282638. DOI: 10.1021/jacs.1c03950.


Discovery and Optimization of Selective Inhibitors of Meprin α (Part I).

Hou S, Diez J, Wang C, Becker-Pauly C, Fields G, Bannister T Pharmaceuticals (Basel). 2021; 14(3).

PMID: 33671080 PMC: 8000592. DOI: 10.3390/ph14030203.